» Articles » PMID: 18614582

Structure of the Influenza Virus A H5N1 Nucleoprotein: Implications for RNA Binding, Oligomerization, and Vaccine Design

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2008 Jul 11
PMID 18614582
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and acts as a key adaptor between the virus and the host cell. It, therefore, plays an important structural and functional role and represents an attractive drug target. Here, we report the 3.3-A crystal structure of H5N1 NP, which is composed of a head domain, a body domain, and a tail loop. Our structure resolves the important linker segments (residues 397-401, 429-437) that connect the tail loop with the remainder of the molecule and a flexible, basic loop (residues 73-91) located in an arginine-rich groove surrounding Arg150. Using surface plasmon resonance, we found the basic loop and arginine-rich groove, but mostly a protruding element containing Arg174 and Arg175, to be important in RNA binding by NP. We also used our crystal structure to build a ring-shaped assembly of nine NP subunits to model the miniribonucleoprotein particle previously visualized by electron microscopy. Our study of H5N1 NP provides insight into the oligomerization interface and the RNA-binding groove, which are attractive drug targets, and it identifies the epitopes that might be used for universal vaccine development.

Citing Articles

Structure of the tilapia lake virus nucleoprotein bound to RNA.

Arragain B, Pelosse M, Huard K, Cusack S Nucleic Acids Res. 2025; 53(4).

PMID: 39995042 PMC: 11850232. DOI: 10.1093/nar/gkaf112.


Addressing unexpected bacterial RNA safety concerns of E. coli produced influenza NP through CpG loaded mutant.

Chen C, Li M, Guo A, Guo P, Zhang W, Gu C NPJ Vaccines. 2025; 10(1):32.

PMID: 39955275 PMC: 11829966. DOI: 10.1038/s41541-025-01087-z.


Influenza a virus antiparallel helical nucleocapsid-like pseudo-atomic structure.

Chenavier F, Zarkadas E, Freslon L, Stelfox A, Schoehn G, Ruigrok R Nucleic Acids Res. 2024; 53(3).

PMID: 39673795 PMC: 11797009. DOI: 10.1093/nar/gkae1211.


An Immunoinformatic Approach for Identifying and Designing Conserved Multi-Epitope Vaccines for Coronaviruses.

Ong Y, Tejo B, Yap W Biomedicines. 2024; 12(11).

PMID: 39595095 PMC: 11592158. DOI: 10.3390/biomedicines12112530.


Global remodeling of ADP-ribosylation by PARP1 suppresses influenza A virus infection.

Zhang Z, Uribe I, Davis K, McPherson R, Larson G, Badiee M bioRxiv. 2024; .

PMID: 39345583 PMC: 11430048. DOI: 10.1101/2024.09.19.613696.


References
1.
Ye Q, Krug R, Tao Y . The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature. 2006; 444(7122):1078-82. DOI: 10.1038/nature05379. View

2.
Portela A, Digard P . The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J Gen Virol. 2002; 83(Pt 4):723-734. DOI: 10.1099/0022-1317-83-4-723. View

3.
Gschoesser C, Almanzar G, Hainz U, Ortin J, Schonitzer D, Schild H . CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein. Vaccine. 2002; 20(31-32):3731-8. DOI: 10.1016/s0264-410x(02)00355-9. View

4.
Roti M, Yang J, Berger D, Huston L, James E, Kwok W . Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. J Immunol. 2008; 180(3):1758-68. PMC: 3373268. DOI: 10.4049/jimmunol.180.3.1758. View

5.
Kreijtz J, de Mutsert G, van Baalen C, Fouchier R, Osterhaus A, Rimmelzwaan G . Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol. 2008; 82(11):5161-6. PMC: 2395172. DOI: 10.1128/JVI.02694-07. View